Gayatri BioOrganics Limited (BOM:524564)
India · Delayed Price · Currency is INR 6.90
+0.03 (0.44%)
At close: Jul 31, 2026
Gayatri BioOrganics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 0.2 | 0.2 | 0.31 | 0.25 | 0.33 |
Cash & Short-Term Investments | 0.2 | 0.2 | 0.31 | 0.25 | 0.33 |
Cash Growth | -2.10% | -34.10% | 24.00% | -24.01% | -92.48% |
Accounts Receivable | 2.54 | 2.54 | 2.54 | 2.54 | 4.85 |
Other Receivables | - | 8.46 | - | - | 2.44 |
Receivables | 2.54 | 11 | 2.54 | 2.54 | 7.28 |
Prepaid Expenses | - | - | 0 | 0 | 0.01 |
Other Current Assets | 14.44 | 5.43 | 12.92 | 13.37 | 13.81 |
Total Current Assets | 17.18 | 16.63 | 15.77 | 16.16 | 21.43 |
Long-Term Investments | - | - | - | - | 0.02 |
Other Long-Term Assets | - | 0 | - | - | 0.91 |
Total Assets | 17.18 | 16.64 | 15.77 | 16.16 | 22.36 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1.67 | 2.02 | 1.77 | 2.13 | 4.69 |
Accrued Expenses | 9.2 | 4.54 | 2.07 | 2.27 | 1.36 |
Short-Term Debt | 24.04 | 334.04 | 334.04 | 334.04 | 334.04 |
Total Current Liabilities | 34.91 | 340.59 | 337.87 | 338.44 | 340.09 |
Long-Term Debt | 352.31 | 34.97 | 29.57 | 22.57 | 17.02 |
Other Long-Term Liabilities | -0 | - | - | - | - |
Total Liabilities | 387.22 | 375.57 | 367.44 | 361.01 | 357.11 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 787.88 | 787.88 | 787.88 | 787.88 | 787.88 |
Additional Paid-In Capital | - | 29.93 | 29.93 | 29.93 | 29.93 |
Retained Earnings | - | -1,178 | -1,170 | -1,164 | -1,154 |
Comprehensive Income & Other | -1,158 | 1 | 1 | 1 | 1 |
Total Common Equity | -370.05 | -358.93 | -351.67 | -344.86 | -334.75 |
Shareholders' Equity | -370.05 | -358.93 | -351.67 | -344.86 | -334.75 |
Total Liabilities & Equity | 17.18 | 16.64 | 15.77 | 16.16 | 22.36 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 376.36 | 369.01 | 363.61 | 356.61 | 351.05 |
Net Cash (Debt) | -376.16 | -368.8 | -363.3 | -356.36 | -350.72 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -4.74 | -4.68 | -4.61 | -4.52 | -4.45 |
Filing Date Shares Outstanding | 84.1 | 78.79 | 78.79 | 78.79 | 78.79 |
Total Common Shares Outstanding | 84.1 | 78.79 | 78.79 | 78.79 | 78.79 |
Working Capital | -17.74 | -323.96 | -322.09 | -322.28 | -318.66 |
Book Value Per Share | -4.40 | -4.56 | -4.46 | -4.38 | -4.25 |
Tangible Book Value | -370.05 | -358.93 | -351.67 | -344.86 | -334.75 |
Tangible Book Value Per Share | -4.40 | -4.56 | -4.46 | -4.38 | -4.25 |